blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1625402

EP1625402 - DETECTION, CHARACTERIZATION AND TREATMENT OF VIRAL INFECTION AND METHODS THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.11.2014
Database last updated on 14.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Canadian Blood Services
1800 Alta Vista Drive
Ottawa, Ontario K1G 4J5 / CA
[2014/01]
Former [2006/07]For all designated states
Canadian Blood Services
1800 Alta Vista Drive Ottawa
Ontario K1G 4J5 / CA
Inventor(s)01 / HU, Yu-Wen
79F Glen Park Drive
Ottawa, Ontario K1B 3Z1 / CA
02 / BROWN, Earl
71 Sunnycrest Drive
Ottawa, Ontario K2E 5Y6 / CA
 [2006/07]
Representative(s)Lord, Hilton David
Marks & Clerk LLP
90 Long Acre
London WC2E 9RA / GB
[N/P]
Former [2014/01]Lord, Hilton David
Marks & Clerk LLP
90 Long Acre
London
WC2E 9RA / GB
Former [2006/07]Lord, Hilton David
Marks & Clerk 90 Long Acre
London WC2E 9RA / GB
Application number, filing date04726942.813.04.2004
[2006/07]
WO2004CA00544
Priority number, dateUS20030461137P09.04.2003         Original published format: US 461137 P
US20030506779P30.09.2003         Original published format: US 506779 P
[2006/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004090544
Date:21.10.2004
Language:EN
[2004/43]
Type: A2 Application without search report 
No.:EP1625402
Date:15.02.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.10.2004 takes the place of the publication of the European patent application.
[2006/07]
Type: B1 Patent specification 
No.:EP1625402
Date:01.01.2014
Language:EN
[2014/01]
Search report(s)International search report - published on:EP20.10.2005
ClassificationIPC:G01N33/569
[2006/07]
CPC:
C12Q1/701 (EP,US); C07K16/109 (EP,US); C12Q1/6883 (EP,US);
C12Q1/703 (EP,US); C12Q1/706 (EP,US); C12Q1/708 (EP,US);
G01N33/56983 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/07]
TitleGerman:VERFAHREN ZUM NACHWEIS, ZU DER BESTIMMUNG UND ZU DER BEHANDLUNG VON VIRALINFEKTIONEN[2013/31]
English:DETECTION, CHARACTERIZATION AND TREATMENT OF VIRAL INFECTION AND METHODS THEREOF[2006/07]
French:DETECTION, CARACTERISATION ET TRAITEMENT D'INFECTIONS VIRALES, ET PROCEDES ASSOCIES[2006/07]
Former [2006/07]VERFAHREN ZUM NACHWEISS, ZU DER BESTIMMUNG UND ZU DER BEHANDLUNG VON VIRALINFEKTIONEN
Entry into regional phase09.11.2005National basic fee paid 
09.11.2005Designation fee(s) paid 
09.11.2005Examination fee paid 
Examination procedure09.11.2005Examination requested  [2006/07]
24.01.2006Amendment by applicant (claims and/or description)
24.02.2009Despatch of a communication from the examining division (Time limit: M06)
24.07.2009Reply to a communication from the examining division
02.03.2010Despatch of a communication from the examining division (Time limit: M04)
08.07.2010Reply to a communication from the examining division
05.12.2011Despatch of a communication from the examining division (Time limit: M06)
20.04.2012Reply to a communication from the examining division
05.07.2013Communication of intention to grant the patent
15.11.2013Fee for grant paid
15.11.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.02.2009
Opposition(s)02.10.2014No opposition filed within time limit [2014/50]
Fees paidRenewal fee
17.03.2006Renewal fee patent year 03
12.04.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
27.04.2009Renewal fee patent year 06
28.04.2010Renewal fee patent year 07
26.04.2011Renewal fee patent year 08
27.04.2012Renewal fee patent year 09
25.04.2013Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.04.2004
AT01.01.2014
BE01.01.2014
BG01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SI01.01.2014
SK01.01.2014
TR01.01.2014
GR02.04.2014
IE13.04.2014
LU13.04.2014
PT02.05.2014
[2016/33]
Former [2016/32]HU13.04.2004
AT01.01.2014
BE01.01.2014
BG01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SI01.01.2014
SK01.01.2014
GR02.04.2014
IE13.04.2014
LU13.04.2014
PT02.05.2014
Former [2016/28]AT01.01.2014
BE01.01.2014
BG01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SI01.01.2014
SK01.01.2014
GR02.04.2014
IE13.04.2014
LU13.04.2014
PT02.05.2014
Former [2016/25]AT01.01.2014
BE01.01.2014
BG01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SI01.01.2014
SK01.01.2014
IE13.04.2014
LU13.04.2014
PT02.05.2014
Former [2015/24]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SI01.01.2014
SK01.01.2014
IE13.04.2014
LU13.04.2014
PT02.05.2014
Former [2015/21]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SK01.01.2014
IE13.04.2014
LU13.04.2014
PT02.05.2014
Former [2015/01]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SK01.01.2014
LU13.04.2014
PT02.05.2014
Former [2014/52]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
MC01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SK01.01.2014
PT02.05.2014
Former [2014/50]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
PL01.01.2014
RO01.01.2014
SE01.01.2014
SK01.01.2014
PT02.05.2014
Former [2014/49]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
RO01.01.2014
SE01.01.2014
PT02.05.2014
Former [2014/48]AT01.01.2014
BE01.01.2014
CY01.01.2014
CZ01.01.2014
EE01.01.2014
ES01.01.2014
FI01.01.2014
SE01.01.2014
PT02.05.2014
Former [2014/41]AT01.01.2014
BE01.01.2014
CY01.01.2014
ES01.01.2014
FI01.01.2014
SE01.01.2014
PT02.05.2014
Former [2014/37]AT01.01.2014
CY01.01.2014
ES01.01.2014
FI01.01.2014
SE01.01.2014
PT02.05.2014
Cited inInternational search[YD]  - BECK, S. AND BARRELL, B.G., "Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I-antigens", NATURE, (19880121), vol. 331, pages 269 - 272, XP001183297 [YD] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *

DOI:   http://dx.doi.org/10.1038/331269a0
 [X]  - BARNETT, L.A. ET AL, "Molecular mimicry: a mechanism for autoimmune injury", FASEB, (1992), vol. 6, no. 3, pages 840 - 844, XP009036267 [X] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *
 [X]  - OLESZAK, E. L., "Molecular mimicry between Fc receptors and viral antigens", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALE, (1994), vol. 42, pages 83 - 88, XP009036920 [X] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *
 [DY]  - KATO N ET AL, "GENETIC DRIFT IN HYPERVARIABLE REGION 1 OF THE VIRAL GENOME IN PERSISTENT HEPATITIS C VIRUS INFECTION", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199408), vol. 68, no. 8, ISSN 0022-538X, pages 4776 - 4784, XP001120895 [DY] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *
 [XD]  - ZHAO, Z. S. ET AL, "Molecular mimicry by Herpex simplex virus-Type-1: autoimmune disease after viral infection", SCIENCE, (1998), vol. 279, pages 1344 - 1347, XP001183296 [XD] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.279.5355.1344
 [X]  - NATALE, C. ET AL, "Computer-assisted analysis of molecular mimicry between human papilloma virus 16 E7 oncoprotein and human protein sequences", IMMUNOLOGY AND CELL BIOLOGY, (2000), vol. 78, pages 580 - 585, XP002298030 [X] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1440-1711.2000.00949.x
 [PY]  - OLESZAK EL ET AL, "Severe acute respiratory syndrome coronavirus and viral mimicry", THE LANCET, (20030614), vol. 361, page 2081, XP002298031 [PY] 1-12,44-77,89-96,128-131,145-149,153-164 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.